UroGen Pharma Ltd. (URGN)

URGN trades at $19.7, 40.7% above the near-term max pain of $14 expiring Sep 19, 2025 (28 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($9-$6284.9), signaling increased put positioning or downside protection. Key magnetic zone at 15 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for URGN shows a downward trend from 6284.9 to 9, indicating bearish sentiment or hedging activity. The 884% spread signals divergent expectations across timeframes. Most levels below 19.7 may cap rallies. Strong magnetic level at 15 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.